RECENT TREATMENT APPROACHES IN NANOPARTICLES DRUG DELIVERY SYSTEM

Mr. Tushar Agarwal Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh 201308, tusharbansal4877@gmail.com
Dr. Sushma Verma Associate Professor, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh 201308.

Abstract

Recent developments in understanding the pharmacokinetic & pharmacodynamics behavior of drugs provide a more realistic approach to developing an efficient drug supply system. It is now appreciable that potential progress in research on drug delivery will mainly benefit from multidisciplinary efforts where a therapeutic agent that can be more efficient and effective and boost the drug delivery system offers lucrative marketing opportunities for pharmaceutical companies and advances in the treatment of mental health conditions. Ideally designed drug delivery systems deliver a certain amount of medication to specific locations at a suitable time and rate as determined or wanted by the body's etiological and physiological needs. Conventional pharmaceutical dosage types cannot manage the rate of delivery of drugs to the target site. Since the distribution of medicines in non-target tissue and body fluids requires therapeutic doses that may exceed the amount required in the target cells, the highest doses also lead to serious adverse effects during therapy; new medicine delivery systems (NDDS) carry drug levels for longer periods.

Keywords:

Drug delivery system, Nano-particles, Therapeutic agents, Target sites.


Full Text:

PDF


References


1. Charman w.n, chank, Finnin BC & chairman SA drug delivery: a key factor in realizing the full therapeutic potential of a drug. Drug development research, 1999; 46: 316-27. 2. Yezdani Umama, Md. Khan Gayoor, Venkatajah G, Rav Shourabh, Roshan Kumar, Arvind Verma, Ayush Kumar. The Scenario of Pharmaceuticals and Development of microwave-assisted extraction techniques. World Journal of Pharmacy and Pharmaceutical science.2019; 8(7):1260-1271. 3. Roop k Khar, s.p Vyas, Farhan j ahmed, Gaurav k jain "the theory and practice of industrial pharmacy "4th edition lachman's/lieberman's cbs distributors, 2013; 872, 902, 905, 943. 4. Kumar Roshan, Priya damwani,Shivam kumar, Adarsh suman ,Suthar Usha. An overview on health benefits and risk factor associated with coffee.International Journal Research and Analytical Review.2020; 7(2)237-249 5. Santini JT, Richards Ac, scheidt R, cima MJ and longer R. Microchips as controlled drug delivery devices angew chem. Int. Td, 2000; 39: 23, 96-407. 6. Kopeek J. Smart & genetically engineered biomaterials & drug delivery systems. European journal pharmaceutical science, 2003; 20: 1-16. 7. Torchilin v.p structure & design polymeric surfactant- based drug delivery systems, journal of controlled release, 2001; 73: 137-172. 8. Haag R. Supramolecular Drug-Delivery Systems based on Polymeric Core-Shell Architectures. Angew. Chem. Int. Ed, 2004; 43: 278-82. 9. Bae Y, Fukushima S, Harada A and Kataoka K, Design of Environment-Sensitive Supramolecular Assemblies for Intracellular Drug Delivery. Polymeric Micelles that are Responsive to Intracellular pH Change. Angew. Chem. Int. Ed, 2003; 4640: 42-43. 10. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 2001; 70: 1-20. 11. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro and nanoparticles in drug delivery. Journal of Controlled Release, 2004; 100: 5-28. 12. lByrne ME, Park K, Peppas N. Molecular imprinting within hydrogels, Advanced Drug Delivery Reviews 2002; 54: 149-61. 11. Sood A and Panchagnula R. Peroral Route: A 13. .Purabi saha, Kajal mishra,Rajni Bala,Roshan Kumar*,Shivam Kumar.A Comprehenshive Review on Paclitaxel and its Envolving role in the Management of Ovarian Cancer.International Journal Research and Analytical Review.2020;7(3)430-442. 14. Soumitra Sahana, Roshan kumar,Sourav nag, Reshmi paul, Nilayan guha,Indranil Chatterjee. A Review on Alzheimer disease and future prospects. World Journal of Pharmacy and Pharmaceutical science.2020; 9(9):1276-1285. 15. Jiang W, Kim BY, Rutka JT, Chan WC. Advances and challenges of nanotechnology-based drug delivery systems. Expert opinion on drug delivery. 2007 Nov 1;4(6):621-33. 16. Bonard JM, Kind H, Stockli, Nilsson LA. Field Emission from Carbon Nanotubes: The First Five Years. Solid-State Electronics 2001; 45: 893 – 914. 17. Ajayan PM. Nanotubes from Carbon, Chem. Rev. 1999; 18. Dresselhaus MS, Dresselhaus G, Eklund PC. Science of Fullerenes and Carbon Nanotubes. Academic Press; New York, 1996 1787–99.. 18. Santini, Jr JT, Richards AC, Scheidt R, Cima MJ, Langer R. Microchips as controlled drug‐delivery devices. Angewandte Chemie International Edition. 2000 Jul 17;39(14):2396-407. 19. Dario P, Carrozza MC, Benvenuto A, Menciassi A. Micro-systems in biomedical applications. Journal of Micromechanics and Microengineering. 2000 Jun 1;10(2):235. 20. Bruguerolle B, Lemmer B. Recent advances in chronopharmacokinetics: methodological problems. Life sciences. 1993 Jan 1;52(23):1809-24.Corveleyn S, Remon, JP. International Journal of Pharmaceutical Science 1997; 152: 215-225. 21. Corveleyn S, Remon JP. Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug. International Journal of Pharmaceutics. 1997 Jun 26;152(2):215-25. 22. Tomalia DA, Reyna LA, Svenson S: Biochem. Soc. Trans, 2007; 35: 61-67. 25. Szoka F. Annu. Rev. Biophysics. Bioengineering, 1980; 9: 467-508 23. Tóth É, Bolskar RD, Borel A, González G, Helm L, Merbach AE, Sitharaman B, Wilson LJ. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. Journal of the American Chemical Society. 2005 Jan 19;127(2):799-805. 24. Bolskar RD, Benedetto AF, Husebo LO, Price RE, Jackson EF, Wallace S, Wilson LJ, Alford JM. First soluble M@ C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@ C60 [C (COOH) 2] 10 as a MRI contrast agent. Journal of the American Chemical Society. 2003 May 7;125(18):5471-8. 25. Sitharaman B, Tran LA, Pham QP, Bolskar RD, Muthupillai R, Flamm SD, Mikos AG, Wilson LJ. Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contrast media & molecular imaging. 2007 May;2(3):139-46. 26. Khan MG. Topic–The Novel Drug Delivery System. World Journal of Pharmacy and Pharmaceutical Sciences. 2017 May 13:477-87. 27. kumar Roshan, Sanjana kumari, Passang Lham, Raeen Mohd Rashid, Anjali Barodiya, Sinha Akshita. Diagnosis and Management of Acute Heart Failure World Journal of Pharmacy and Pharmaceutical science.2020; 9(8)2510-2517 28. Soumitra Sahana,Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science.2020; 9(9):2367-2381 29. Roshan kumar,*Purabi Saha, Rakesh Kumar Arya, Abhishek kumar. A Review on Pharmacology Medication of Corona Virus.World Journal of Pharmacy and Pharmaceutical science.2020; 9(10):693-711 30. Roshan kumar, Purabi Saha*, Yogendra kumar, Soumitra Sahana, Binita kumari,Vishnu Mittal,Sahenur Begum, Sibam padhy, Nayan kumar. Systematic Review on Risk Factor leading to Peptic Ulcer Disease..World Journal of Pharmacy and Pharmaceutical science.2020; 9(11):504-515. 31. Chaturvedi M, Kumar M, Sinhal A, Alimuddin Saifi. Recent development in novel drug delivery systems of herbal drugs. International journal of Green Pharmacy, 2011; 5: 87-94. 32. Amol K, Pratibha P. NOVEL DRUG DELIVERY SYSTEM IN HERBAL'S. International Journal of Pharmaceutical, Chemical & Biological Sciences. 2014 Oct 1;4(4). 33. Aravajhala V, Papishetty S, Bandlapalli S. Nanotechnology In Development Of Drug Delivery System. International Journal of Pharmaceutics Science and Research, 2012; 3(1): 84-96. 34. .Manmode AS, Sakarka DM, Mahajan NM. Nanoparticles- Tremendous Therapeutic Potential: A Review. International Journal of PharmTech Research, 2009; 1(4): 1020-1027. 35. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. The American journal of clinical nutrition. 2004 May 1;79(5):727-47.

Refbacks

  • There are currently no refbacks.